Federal award
OTOLOGIC PHARMACEUTICS, INC
N6264512C4037
Contract
Obligated and Ceiling
- Obligated (net)
- $688,599.96
- Ceiling (potential value, not spending)
- $688,599.96
- Current value
- $688,599.96
- Gross positive obligations
- $688,600.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- OTOLOGIC PHARMACEUTICS, INC · MCYMZ54X6TK3
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- OTOLOGIC PHARMACEUTICS, INC · MCYMZ54X6TK3
- Awarding agency
- Department of War · sub-agency 1700 · office N62645
- Funding agency
- Department of War · sub-agency 1700
- Product or service (PSC)
- AN42 · HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH
- Industry (NAICS)
- 541711 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
- PIID
- N6264512C4037
- Award type code
- D
- Actions
- 4 · Aug 13, 2012 to Oct 10, 2013
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History4
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Oct 10, 2013 | FY2014 | P00003 | M | $0.00 | — |
| Jan 30, 2013 | FY2013 | P00002 | M | $0.00 | — |
| Sep 6, 2012 | FY2012 | P00001 | M | −$0.04 | — |
| Aug 13, 2012 | FY2012 | 0 | — | $688,600.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.